000			01809 a2200505 4500
005			20250513053346.0
264		0	_c19941229
008			199412s 0 0 eng d
022			_a0039-2499
024	7		_a10.1161/01.str.25.12.2450 _2doi
040			_aNLM _beng _cNLM
100	1		_aWillette, R N
245	0	0	_aNonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. _h[electronic resource]
260			_bStroke _cDec 1994
300			_a2450-5; discussion 2456 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aArteries _xdrug effects
650	0	4	_aBasilar Artery _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCerebral Arteries _xdrug effects
650	0	4	_aCerebrovascular Circulation _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDogs
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEndothelin Receptor Antagonists
650	0	4	_aEndothelins _xagonists
650	0	4	_aIndans _xadministration & dosage
650	0	4	_aIschemic Attack, Transient _xetiology
650	0	4	_aMale
650	0	4	_aMitogens
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aSpinal Cord _xblood supply
650	0	4	_aSubarachnoid Hemorrhage _xcomplications
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aVasoconstrictor Agents _xpharmacology
650	0	4	_aViper Venoms _xpharmacology
700	1		_aZhang, H
700	1		_aMitchell, M P
700	1		_aSauermelch, C F
700	1		_aOhlstein, E H
700	1		_aSulpizio, A C
773	0		_tStroke _gvol. 25 _gno. 12 _gp. 2450-5; discussion 2456
856	4	0	_uhttps://doi.org/10.1161/01.str.25.12.2450 _zAvailable from publisher's website
999			_c7973921 _d7973921